The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Devapamil ID: ALA2074792
Cas Number: 92302-55-1
PubChem CID: 65832
Max Phase: Phase
Molecular Formula: C26H36N2O3
Molecular Weight: 424.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Desmethoxyverapamil | D 888 | Devapamil|92302-55-1|Devapamil [INN]|Devapamilum|Devapamilo|Desmethoxyverapamil|(+/-)-Devapamil|2-(3,4-Dimethoxyphenyl)-2-isopropyl-5-((m-methoxyphenethyl)methylamino)valeronitrile|M6142PTV7J|CHEBI:34673|2-(3,4-dimethoxyphenyl)-5-[2-(3-methoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile|D 888; Desmethoxyverapamil; Devapamil|D 888|Devapamilum [Latin]|Devapamilo [Spanish]|2-(3,4-dimethoxyphenyl)-2-isopropyl-5-{[2-(3-methoxyphenyl)ethyl](methyl)amino}pentaneni Show More⌵
Canonical SMILES: COc1cccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)c1
Standard InChI: InChI=1S/C26H36N2O3/c1-20(2)26(19-27,22-11-12-24(30-5)25(18-22)31-6)14-8-15-28(3)16-13-21-9-7-10-23(17-21)29-4/h7,9-12,17-18,20H,8,13-16H2,1-6H3
Standard InChI Key: VMVKIDPOEOLUFS-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 32 0 0 0 0 0 0 0 0999 V2000
-1.2208 -0.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8458 -0.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7000 0.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1191 1.1137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8250 -1.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4500 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0875 -1.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4833 -0.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1000 -0.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5958 -0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5042 1.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 1.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3375 1.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4458 -2.4417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0917 1.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5875 1.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7542 1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6583 0.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7125 -1.7417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2542 1.5083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7458 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8292 2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 1.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2500 2.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5000 2.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 0.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5958 -1.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0375 -0.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8000 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3417 0.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 3 0
5 2 1 0
6 5 2 0
7 9 2 0
8 2 2 0
9 8 1 0
10 1 1 0
11 23 1 0
12 13 2 0
13 17 1 0
14 6 1 0
15 11 1 0
16 12 1 0
17 15 1 0
18 1 1 0
19 7 1 0
20 16 1 0
21 18 1 0
22 24 2 0
23 21 1 0
24 13 1 0
25 22 1 0
26 11 1 0
27 10 1 0
28 10 1 0
29 14 1 0
30 19 1 0
31 20 1 0
6 7 1 0
16 25 2 0
M END
Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 424.59Molecular Weight (Monoisotopic): 424.2726AlogP: 5.08#Rotatable Bonds: 12Polar Surface Area: 54.72Molecular Species: BASEHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.69CX LogP: 5.20CX LogD: 2.94Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.48Np Likeness Score: -0.24
References 1. Höllt V, Kouba M, Dietel M, Vogt G.. (1992) Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein., 43 (1): [PMID:1352973 ] [10.1016/0006-2952(92)90149-d ] 2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date,